The Cancer Immunotherapy Market was valued at approximately USD 120 billion in 2023 and is expected to grow at a substantial CAGR of around 10% during the forecast period (2024-2032)
Since the early 2000s, cancer immunotherapy has emerged as one of the most transformative advancements in oncology, fundamentally changing how cancer is treated. Unlike conventional therapies, immunotherapy...
Sobre
Termos
Privacidade
Contact
Invest
Thai
English
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian